Shopping Cart
- Remove All
- Your shopping cart is currently empty
Prinomastat (AG3340) is an orally active and selective inhibitor of metalloproteinases (MMPs) that crosses the blood-brain barrier.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 71 € | In Stock | |
5 mg | 282 € | In Stock | |
10 mg | 514 € | In Stock | |
25 mg | 815 € | In Stock |
Description | Prinomastat (AG3340) is an orally active and selective inhibitor of metalloproteinases (MMPs) that crosses the blood-brain barrier. |
Targets&IC50 | MMP1:79 nM, MMP9:0.26 nM (ki), MMP9:5 nM, MMP2:0.05 nM (ki), MMP3:0.3 nM (ki), MMP3:6..3 nM |
In vitro | In C57MG/Wnt1 cells, Prinomastat (0.1 µg/mL, 1 µg/mL; 4 days) significantly decreases MMP-3 promoter activity[1]. |
In vivo | In a human fibrosarcoma mouse model (HT1080), Prinomastat (50 mg/kg; intraperitoneal injection) is well tolerated by the animals, and exhibits significant tumor growth inhibition. It has a short half-life of 1.6 hours. |
Alias | KB-R9896, AG3340 |
Molecular Weight | 423.51 |
Formula | C18H21N3O5S2 |
Cas No. | 192329-42-3 |
Smiles | CC1(C)SCCN([C@H]1C(=O)NO)S(=O)(=O)c1ccc(Oc2ccncc2)cc1 |
Relative Density. | 1.377g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 1 mg/mL (2.36 mM), Sonication is recommended. H2O: 1 mg/mL (2.36 mM), Sonication and adjust pH to 3 with 1M HCl | ||||||||||
Solution Preparation Table | |||||||||||
DMSO/H2O
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.